Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lal, Harbans
1994.
Biochemical studies in head and neck cancer.
Clinical Biochemistry,
Vol. 27,
Issue. 4,
p.
235.
Gardani, Carla Fernanda Furtado
Cappellari, Angélica Regina
de Souza, Julia Brandt
da Silva, Bruna Tertuliano
Engroff, Paula
Moritz, Cesar Eduardo Jacintho
Scholl, Juliete Nathali
Battastini, Ana Maria Oliveira
Figueiró, Fabrício
and
Morrone, Fernanda Bueno
2019.
Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients.
Purinergic Signalling,
Vol. 15,
Issue. 1,
p.
95.
Morello, Silvana
Turiello, Roberta
Madonna, Gabriele
Pinto, Aldo
Ascierto, Paolo A.
and
Capone, Mariaelena
2019.
Tumor Immunology and Immunotherapy – Molecular Methods.
Vol. 629,
Issue. ,
p.
257.
Muñóz-Godínez, Ricardo
de Lourdes Mora-García, María
Weiss-Steider, Benny
Montesinos-Montesinos, Juan José
del Carmen Aguilar-Lemarroy, Adriana
García-Rocha, Rosario
Hernández-Montes, Jorge
Azucena Don-López, Christian
Ávila-Ibarra, Luis Roberto
Torres-Pineda, Daniela Berenice
Molina-Castillo, Gabriela
Chacón-Salinas, Rommel
Vallejo-Castillo, Luis
Pérez-Tapia, Sonia Mayra
Monroy-García, Alberto
and
Valacchi, Giuseppe
2020.
Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression.
Mediators of Inflammation,
Vol. 2020,
Issue. ,
p.
1.
Turiello, Roberta
Pinto, Aldo
and
Morello, Silvana
2020.
CD73: A Promising Biomarker in Cancer Patients.
Frontiers in Pharmacology,
Vol. 11,
Issue. ,
Turiello, Roberta
Capone, Mariaelena
Giannarelli, Diana
Morretta, Elva
Monti, Maria Chiara
Madonna, Gabriele
Mallardo, Domenico
Festino, Lucia
Azzaro, Rosa
Levesque, Mitchell P
Imhof, Laurence
Weide, Benjamin
Amaral, Teresa
Chevrier, Marc
Sucker, Antje
Rutkowski, Piotr
Schadendorf, Dirk
Lebbe, Celeste
Luke, Jason John
Wistuba-Hamprecht, Kilian
Dummer, Reinhard
Pinto, Aldo
Morello, Silvana
and
Ascierto, Paolo A
2020.
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Journal for ImmunoTherapy of Cancer,
Vol. 8,
Issue. 2,
p.
e001689.
Coray, Mali
Göldi, Veronika
Schmid, Lukas
Benecke, Laura
Figueiró, Fabrício
and
Muller, Laurent
2022.
Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.
International Journal of Molecular Sciences,
Vol. 23,
Issue. 22,
p.
14446.
Giraulo, Caterina
Orlando, Lavinia
Morretta, Elva
Voli, Antonia
Plaitano, Paola
Cicala, Carla
Potaptschuk, Eugen
Müller, Christa E.
Tosco, Alessandra
Monti, Maria Chiara
and
Morello, Silvana
2024.
High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells.
Biomedicine & Pharmacotherapy,
Vol. 177,
Issue. ,
p.
117033.